Azione HTGMQ HTG MOLECULAR DIAGNOSTICS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue HTG Molecular Diagnostics, Inc.

Azioni

HTGMQ

US40434H3021

Tempo differito OTC Markets
Altri mercati azionari
 15:30:42 20/06/2024 		Variaz. 5gg Var. 1 gen.
0,0015 USD -40,00% Grafico intraday di HTG Molecular Diagnostics, Inc. 0,00% +15,38%
2023 Nominato un fiduciario/esaminatore ai sensi del Capitolo 11 per HTG Molecular Diagnostics, Inc. CI
2023 Htg Molecular Diagnostics, Inc. annuncia la cessazione del rapporto di lavoro di Byron T. Lawson in qualità di Vice Presidente Senior e Direttore Commerciale CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization
Top Premarket Gainers
HTG Highlights the Advantages of Its Drug Discovery Engine
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)
HTG Provides Update on Drug Discovery Partnering Initiative
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione HTGMQ
  4. Notizie HTG Molecular Diagnostics, Inc.
  5. Altre lingue